140 related articles for article (PubMed ID: 20975513)
1. Surgical correction of HIV-associated facial lipoatrophy.
Guaraldi G; Fontdevila J; Christensen LH; Orlando G; Stentarelli C; Carli F; Zona S; de Santis G; Pedone A; De Fazio D; Bonucci P; Martínez E
AIDS; 2011 Jan; 25(1):1-12. PubMed ID: 20975513
[No Abstract] [Full Text] [Related]
2. Bridging a gap: surgical management of HIV-associated lipoatrophy.
Moyle GJ
AIDS Read; 2004 Sep; 14(9):472-5. PubMed ID: 15457598
[No Abstract] [Full Text] [Related]
3. Treatment of facial lipoatrophy in HIV-infected patients.
Prescrire Int; 2008 Aug; 17(96):170. PubMed ID: 19492497
[TBL] [Abstract][Full Text] [Related]
4. Contemporary surgical management of HIV-associated facial lipoatrophy.
Funk E; Bressler FJ; Brissett AE
Otolaryngol Head Neck Surg; 2006 Jun; 134(6):1015-22. PubMed ID: 16730549
[TBL] [Abstract][Full Text] [Related]
5. Restorative interventions for HIV facial lipoatrophy.
Carey D; Liew S; Emery S
AIDS Rev; 2008; 10(2):116-24. PubMed ID: 18615122
[TBL] [Abstract][Full Text] [Related]
6. Correction of facial lipoatrophy using autologous fat transplants in HIV-infected adolescents.
Dollfus C; Blanche S; Trocme N; Funck-Brentano I; Bonnet F; Levan P
HIV Med; 2009 May; 10(5):263-8. PubMed ID: 19178590
[TBL] [Abstract][Full Text] [Related]
7. Facial lipohypertrophy in HIV-infected subjects who underwent autologous fat tissue transplantation.
Guaraldi G; De Fazio D; Orlando G; Murri R; Wu A; Guaraldi P; Esposito R
Clin Infect Dis; 2005 Jan; 40(2):e13-5. PubMed ID: 15655734
[TBL] [Abstract][Full Text] [Related]
8. Approaches to treatment of HIV facial lipoatrophy.
Jones D
Skin Therapy Lett; 2005 Nov; 10(9):5-7. PubMed ID: 16292459
[TBL] [Abstract][Full Text] [Related]
9. Treatment of facial lipoatrophy via autologous fat transfer.
Cohen G; Treherne A
J Drugs Dermatol; 2009 May; 8(5):486-9. PubMed ID: 19537373
[TBL] [Abstract][Full Text] [Related]
10. Relationship between lipoatrophy and quality of life.
Echavez M; Horstman W
AIDS Read; 2005 Jul; 15(7):369-75. PubMed ID: 16044579
[TBL] [Abstract][Full Text] [Related]
11. The impact of facial lipoatrophy treatment with polymethyl methacrylate in AIDS patients as measured by four quality-of-life questionnaires.
Warde M; Gragnani A; Gomes H; Hochman B; Ferreira LM
Int J STD AIDS; 2011 Oct; 22(10):596-9. PubMed ID: 21998182
[TBL] [Abstract][Full Text] [Related]
12. Plastic surgical approaches for HIV-associated lipoatrophy.
Moyle GJ
Curr HIV/AIDS Rep; 2005 Aug; 2(3):127-31. PubMed ID: 16091259
[TBL] [Abstract][Full Text] [Related]
13. Treatment of human immunodeficiency virus-associated facial lipoatrophy with lipofilling and submalar silicone implants.
Mori A; Lo Russo G; Agostini T; Pattarino J; Vichi F; Dini M
J Plast Reconstr Aesthet Surg; 2006; 59(11):1209-16. PubMed ID: 17046631
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of facial lipoatrophy by lipofilling in HIV infected patients: retrospective study on 317 patients on 9 years].
Uzzan C; Boccara D; Lacheré A; Mimoun M; Chaouat M
Ann Chir Plast Esthet; 2012 Jun; 57(3):210-6. PubMed ID: 22218365
[TBL] [Abstract][Full Text] [Related]
15. Lipodystrophy and quality of life of HIV-infected persons.
Guaraldi G; Murri R; Orlando G; Squillace N; Stentarelli C; Zona S; Garlassi E; Martínez E
AIDS Rev; 2008; 10(3):152-61. PubMed ID: 18820717
[TBL] [Abstract][Full Text] [Related]
16. A comparison of lipoatrophy and aging: volume deficits in the face.
Coleman S; Saboeiro A; Sengelmann R
Aesthetic Plast Surg; 2009 Jan; 33(1):14-21. PubMed ID: 18987910
[TBL] [Abstract][Full Text] [Related]
17. Human immunodeficiency virus-related lipoatrophy of the face: where should we have to fill?
Rauso R; Tartaro G; Cobellis G; Sangiovanni V; Colella G
Plast Reconstr Surg; 2011 Jun; 127(6):143e-144e. PubMed ID: 21617428
[No Abstract] [Full Text] [Related]
18. [Surgical treatment of lipodystrophy associated with HIV-infection: conclusions of a multidisciplinary meeting].
Fundación para la Formación e Información sobre Tratamientos en el VIH/sida (FIT)
Enferm Infecc Microbiol Clin; 2007 May; 25(5):324-8. PubMed ID: 17504686
[TBL] [Abstract][Full Text] [Related]
19. Porcine filler for facial lipoatrophy associated with human immunodeficiency virus treatment.
Reytan N; Rzany B
J Drugs Dermatol; 2008 Sep; 7(9):884-6. PubMed ID: 19112805
[TBL] [Abstract][Full Text] [Related]
20. A ribose-crosslinked collagen filler treatment for facial lipoatrophy associated with the treatment of human immunodeficiency virus.
Reytan N; Rzany B
J Drugs Dermatol; 2008 Dec; 7(12):1169-71. PubMed ID: 19137772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
